The Venture Codex Logo

The Venture Codex

Eli Lilly and Company

Lilly Corporate Center, Indianapolis, IN, 46285, United States

Overview

Pharmaceutical company focused on drug discovery and development.

Founded

1876

Deals ยท 12mo

24

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology
Health Care
Medical
Pharmaceutical

Investment portfolio

129rounds
NAMEDATESIZE
General Medicine
Oct 2026Participated
$120 MSeries B
BigHat Biosciences
Sep 2026Participated
$75 MSeries C
Circle Pharma
Sep 2026Participated
$93 MSeries E
Thatch
Sep 2026Participated
$108 MSeries C
Caspian Therapeutics
Sep 2026Participated
$50 MOther Equity
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
Moonwalk Biosciences
Sep 2026Participated
$70 MSeries B
Superluminal Medicines
Sep 2026Participated
$60 MSeries B
Leal Therapeutics
Aug 2026Participated
$30 MSeries A
InduPro
Aug 2026Participated
$77 MSeries B
Amplifica
Aug 2026Participated
$26 MSeries B
Remedium Bio
Aug 2026Participated
$10 MSeries A
General Medicine
Oct 2026Participated
$120 MSeries B
BigHat Biosciences
Sep 2026Participated
$75 MSeries C
Circle Pharma
Sep 2026Participated
$93 MSeries E
Thatch
Sep 2026Participated
$108 MSeries C
Caspian Therapeutics
Sep 2026Participated
$50 MOther Equity
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
Moonwalk Biosciences
Sep 2026Participated
$70 MSeries B
Superluminal Medicines
Sep 2026Participated
$60 MSeries B
Leal Therapeutics
Aug 2026Participated
$30 MSeries A
InduPro
Aug 2026Participated
$77 MSeries B
Amplifica
Aug 2026Participated
$26 MSeries B
Remedium Bio
Aug 2026Participated
$10 MSeries A
129
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Eli Lilly and Company: 129 funding rounds are recorded in the selected participation categories.All available history.
Eli Lilly and Company: 129 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed012
Series A149
Series B134
Series C+114
Other Equity98

Monthly Deal Activity

Eli Lilly and Company: 129 deals are recorded across 136 months.All available history.
Eli Lilly and Company: 129 deals are recorded across 136 months. All available history
MonthDeals
Jul '151
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '163
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '161
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '171
Aug '170
Sep '170
Oct '170
Nov '170
Dec '171
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '181
Aug '181
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '191
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '203
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '202
Nov '200
Dec '201
Jan '212
Feb '211
Mar '212
Apr '211
May '210
Jun '214
Jul '212
Aug '211
Sep '214
Oct '212
Nov '211
Dec '211
Jan '221
Feb '221
Mar '221
Apr '220
May '221
Jun '220
Jul '222
Aug '220
Sep '222
Oct '220
Nov '221
Dec '221
Jan '230
Feb '231
Mar '234
Apr '231
May '232
Jun '232
Jul '231
Aug '232
Sep '233
Oct '230
Nov '233
Dec '230
Jan '241
Feb '241
Mar '242
Apr '240
May '243
Jun '241
Jul '242
Aug '241
Sep '244
Oct '242
Nov '242
Dec '240
Jan '251
Feb '250
Mar '254
Apr '252
May '254
Jun '252
Jul '250
Aug '252
Sep '252
Oct '253
Nov '251
Dec '253
Jan '262
Feb '260
Mar '261
Apr '260
May '260
Jun '262
Jul '262
Aug '264
Sep '267
Oct '261

Sector Breakdown

Eli Lilly and Company: Health & Life Sciences is the largest displayed sector by deal count (128 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Eli Lilly and Company: Health & Life Sciences is the largest displayed sector by deal count (128 deals). All available history
SectorDeals
Health & Life Sciences128
AI & Machine Learning15
Space & Frontier Tech14
Enterprise Software5
Consumer & Lifestyle1
Networks, Cloud & Communication1
Marketing & Advertising1
Fintech1
Manufacturing1
Professional Services1

Deal Size Distribution

Eli Lilly and Company: 129 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Eli Lilly and Company: 129 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M5
$10M-$25M19
$25M-$50M35
$50M-$100M45
$100M-$250M21
$250M-$500M2
$500M-$1B0
$1B+0

Deals By Geography

Eli Lilly and Company: United States has the largest recorded deal count among the displayed regions (103 deals).All available history.

Top 6 of 6 regions; European countries are grouped as Europe.

Eli Lilly and Company: United States has the largest recorded deal count among the displayed regions (103 deals). All available history
RegionDeals
United States103
Europe21
Canada2
Australia1
South Korea1
Japan1
Eli Lilly and Company: 20 co-investors are shown, with Alexandria Venture Investments sharing 29 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Eli Lilly and Company: 20 co-investors are shown, with Alexandria Venture Investments sharing 29 recorded deals. All available history
Co-investorShared deals
Alexandria Venture Investments29
Pfizer Ventures16
Johnson & Johnson Innovation13
ARCH Venture Partners12
Polaris Partners11
SV Health Investors11
RA Capital Management10
AbbVie Ventures8
Invus8
Casdin Capital7
Catalio Capital Management7
RTW Investments7
Sofinnova Partners7
Andreessen Horowitz6
Forbion6
MRL Ventures Fund6
Novartis6
OrbiMed6
WuXi AppTec6
Boxer Capital5

Investment Strategy

Eli Lilly and Company: Led accounts for 9% and participating for 91% of round participation.All available history.
Eli Lilly and Company: Led accounts for 9% and participating for 91% of round participation. All available history
CategoryDeals (count)Share (%)
Led129%
Participating11791%
Eli Lilly and Company: Single-lead accounts for 58% and co-led for 42% of lead dynamics.All available history.
Eli Lilly and Company: Single-lead accounts for 58% and co-led for 42% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead758%
Co-led542%

Team

Barton R. Peterson

Senior Vice President, Corporate Affairs & Communications

Eli Lilly

Founder

Eric Dozier

SVP, Human Resources, and Diversity

Frances Sexton

Material Management Technical Support

Gervais Johnson

Director

Jan Gerbers

Wholesale Drug Distributor Licensing Consultant

Kuldeep Neote

Vice President External Innovation

Marie Murphy

Principal Research Scientist, Technical Services Manufacturing Network

Ronald DeMattos

Senior Vice President and Chief Scientific Officer Neurobiologics